Exploring Synergies: How Biotech Companies and Startups Can Drive Breakthrough Therapies
Bio Invest | Company results | By Hithaishi C Bhaskar | 0 Comment | 28 Jul, 2023
Leading global biotechnology company Amgen and NSG BioLabs, Singapore’s largest provider of biotech co-working lab...Read more
ASEAN Businesses to get funding for mediating IP or technology disputes
Bio Invest | Regulatory | 0 Comment | 03 Jul, 2023
Businesses in the Association of Southeast Asian Nations (ASEAN) can now benefit from subsidised mediation ...Read more
SomaLogic unveils first-ever proteomics grant program to APAC life sciences researchers
Bio Invest | News | 0 Comment | 08 May, 2023
SomaLogic, Inc., a global leader in proteomics technology, has announced tis first grant in the APAC region by spon...Read more
Is Asian life sciences industry losing confidence in US after SVB failure?
Bio Invest | News | 0 Comment | 14 Mar, 2023
The sudden collapse of a major bank- Silicon Valley Bank (SVB)- in the United States (US) might have unexpected conseque...Read more
Bio Invest | News | 0 Comment | 10 Mar, 2023
On March 10th, The Wharton School of the University of Pennsylvania kicked off the 55th Wharton Global Forum i...Read more
Tanaka makes equity contribution for establishing medical venture ecosystem in Japan
Bio Invest | News | 0 Comment | 20 Dec, 2022
Tokyo based TANAKA Kikinzoku Kogyo K.K. has made an equity contribution to the medical venture capital fund 'Diamond Med...Read more
Bio Invest | Opinion | By Hithaishi C Bhaskar | 0 Comment | 12 Oct, 2022
Meaningful partnerships and collaborations are indispensable to narrow the disparities among stakeholders in a multiface...Read more
ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist
Bio Invest | News | 0 Comment | 28 Sep, 2022
Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...Read more
Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK and Singapore
Bio Invest | News | 0 Comment | 17 Sep, 2021
The investments include an expansion of the company’s research and development facility in Cambridge, United Kingd...Read more
The UK government launches 'UK Life Sciences Vision'
Bio Invest | News | 0 Comment | 19 Jul, 2021
The United Kingdom (UK) government aims to accelerate the delivery of novel innovations at patient care through the ...Read more
Adlai Nortye raises $100 M (Series D) to accelerate clinical and drug development programs
Bio Invest | News | 0 Comment | 15 Jul, 2021
Adlai Nortye Ltd., a global biopharmaceutical company focused on developing innovative oncology drugs, has complete...Read more
TVM Capital Healthcare strengthens its leadership in Southeast Asia regions
Bio Invest | News | 0 Comment | 05 Jul, 2021
TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announced that...Read more
Hong Kong's biopharma CDMO extends business development services to investors
Bio Invest | News | 0 Comment | 03 Jun, 2021
Peking University Biologics (PKU BIO) and Norwich Investment Limited (Norwich) announced a Strategic Cooperati...Read more
IFC and Mitsui to invest US$60M in Singapore-based MiCare Health Technologies
Bio Invest | News | 0 Comment | 27 May, 2021
MiCare HealthTEC Holdings Pte Ltd, a subsidiary of Zuellig Pharma and a leading medical claims ...Read more
BIO KOREA 2021 preparing to unravel Biohealth market
Bio Invest | News | 0 Comment | 21 Apr, 2021
The 16th edition of BIO KOREA, the reference B2B event for global biotech and health industry professionals interes...Read more
China's AffaMed Therapeutics completes US$170M Series B financing
Bio Invest | News | 0 Comment | 30 Mar, 2021
Shanghai's AffaMed Therapeutics (“AffaMed”), a global clinical-stage biopharmaceutical company dedicated to ...Read more
Vietnam boosts innovation and startup ecosystem
Bio Invest | News | 0 Comment | 11 Jan, 2021
Vietnam has launched the construction of National Innovation Centre (NIC), worth 740 billion VND ($32 million), spr...Read more
VISEN raises $150M in Series B to accelerate innovative endocrinology therapies in Greater China
Bio Invest | News | 0 Comment | 11 Jan, 2021
VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that addre...Read more